Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -.--% |
Business Summary
Number of employees: 41
Sales per Business
USD in Million | 2006 | Weight | 2007 | Weight | Delta |
---|---|---|---|---|---|
Anti-infective Products
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -36.62% |
Sales per region
USD in Million | 2006 | Weight | 2007 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -36.62% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
John R. Barr
CEO | Chief Executive Officer | 67 | - |
Thomas Higgins
DFI | Director of Finance/CFO | 72 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 53,640,136 | 53,640,136 ( 100.00 %) | 0 | 100.00 % |
Company contact information
Panacos Pharmaceuticals, Inc.
134 Coolidge Avenue
02472, Watertown
+
Sector
1st Jan change | Capi. | |
---|---|---|
-.--% | 53 | |
+3.91% | 108B | |
+10.87% | 104B | |
+1.28% | 22.33B | |
-13.14% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-10.66% | 17.64B | |
+3.75% | 14.05B | |
+36.70% | 12.51B |
- Stock Market
- Equities
- PANC Stock
- Company Panacos Pharmaceuticals, Inc.